| 12410244 |
Anti-alpha-synuclein antibodies |
Patrick Downey, Marco Kriek, Lorenzo De Lichtervelde, Daniel John Lightwood, David James McMillan +2 more |
2025-09-09 |
| 12338285 |
Anti-FcRn antibodies |
Helene Margaret Finney, Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Lara Kevorkian +3 more |
2025-06-24 |
| 12331117 |
Antibody molecules which bind CD22 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2025-06-17 |
| 12247068 |
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders |
Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Karen Inouye +6 more |
2025-03-11 |
| 11746145 |
Tau-binding antibodies |
Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight |
2023-09-05 |
| 11692041 |
Antibody molecules which bind CD45 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2023-07-04 |
| 11518803 |
Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis |
Helene Bon, Joanne Elizabeth Compson, Kate Louise Dixon, Carl Brendan Doyle, Mark Ellis +9 more |
2022-12-06 |
| 11472879 |
Antibody molecules which bind CD22 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2022-10-18 |
| 11384148 |
Anti-FcRn antibodies |
Helene Margaret Finney, Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Lara Kevorkian +3 more |
2022-07-12 |
| 11292831 |
Anti-alpha synuclein antibodies |
Patrick Downey, Marco Kriek, Lorenzo De Lichtervelde, Daniel John Lightwood, David James McMillan +2 more |
2022-04-05 |
| 11261242 |
Anti-alpha-synuclein antibodies |
Ralph Adams, Patrick Downey, Terence Seward Baker, Lorenzo De Lichtervelde, Daniel John Lightwood +1 more |
2022-03-01 |
| 11261252 |
Molecules with specificity for CD79 and CD22 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2022-03-01 |
| 11220547 |
Antibodies specific to FCRN |
Paul Alan Atherfold, Thomas Allen Ceska, Helene Margaret Finney, Lara Kevorkian, Kaushik Sarkar +1 more |
2022-01-11 |
| 11014979 |
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders |
Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Elisabeth Helen Roberts +6 more |
2021-05-25 |
| 10906966 |
Tau-binding antibodies |
Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight |
2021-02-02 |
| 10774152 |
Molecules with specificity for CD45 and CD79 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2020-09-15 |
| 10766956 |
Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis |
Helene Bon, Joanne Elizabeth Compson, Kate Louise Dixon, Carl Brendan Doyle, Mark Ellis +9 more |
2020-09-08 |
| 10752676 |
Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficile |
David Paul Humphreys, Daniel John Lightwood, David Edward Ormonde Knight, Karine Jeannine Madeleine Hervé, Joanne Elizabeth Compson +5 more |
2020-08-25 |
| 10618957 |
Antibody molecules which bind CD79 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2020-04-14 |
| 10590197 |
Antibody molecules which bind CD22 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2020-03-17 |
| 10370447 |
Molecules with specificity for CD79 and CD22 |
Helene Margaret Finney, Stephen Edward Rapecki, Michael John Wright |
2019-08-06 |
| 10344081 |
Tau-binding antibodies |
Terence Seward Baker, Georges Mairet-Coello, Patrick Downey, Jean-Philippe Courade, David Edward Ormonde Knight |
2019-07-09 |
| 10273302 |
Antibodies specific to FcRn |
Paul Alan Atherfold, Thomas Allen Ceska, Helene Margaret Finney, Lara Kevorkian, Kaushik Sarkar +1 more |
2019-04-30 |
| 10233243 |
Anti-FcRn antibodies |
Helene Margaret Finney, Alastair David Griffiths Lawson, Stevan Graham Shaw, Bryan John Smith, Lara Kevorkian +3 more |
2019-03-19 |
| 10160798 |
Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders |
Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Elisabeth Helen Roberts +5 more |
2018-12-25 |
